Jeff Cohen
Stock Analyst at Ladenburg Thalmann
(2.99)
# 1,414
Out of 4,944 analysts
12
Total ratings
72.73%
Success rate
32.89%
Average return
Main Sectors:
Stocks Rated by Jeff Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NMTC NeuroOne Medical Technologies | Initiates: Buy | $1.45 | $0.80 | +80.82% | 1 | May 5, 2025 | |
| CBLL CeriBell | Initiates: Buy | $32 | $11.97 | +167.34% | 1 | Apr 4, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $31 | $14.83 | +109.04% | 1 | Feb 20, 2025 | |
| LGCY Legacy Education | Maintains: Buy | $9.1 → $11 | $11.67 | -7.46% | 2 | Feb 14, 2025 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $3.29 | - | 1 | Nov 15, 2024 | |
| SNOA Sonoma Pharmaceuticals | Initiates: Buy | $65 | $2.95 | +2,103.39% | 1 | Sep 5, 2023 | |
| DKNG DraftKings | Initiates: Overweight | $52 | $43.10 | +20.65% | 1 | Jul 1, 2020 | |
| SE Sea Limited | Initiates: Overweight | $130 | $175.05 | -25.74% | 1 | Jul 1, 2020 | |
| TTWO Take-Two Interactive Software | Maintains: Equal-Weight | $110 → $130 | $232.30 | -44.04% | 3 | May 21, 2020 |
NeuroOne Medical Technologies
May 5, 2025
Initiates: Buy
Price Target: $1.45
Current: $0.80
Upside: +80.82%
CeriBell
Apr 4, 2025
Initiates: Buy
Price Target: $32
Current: $11.97
Upside: +167.34%
Beta Bionics
Feb 20, 2025
Initiates: Buy
Price Target: $31
Current: $14.83
Upside: +109.04%
Legacy Education
Feb 14, 2025
Maintains: Buy
Price Target: $9.1 → $11
Current: $11.67
Upside: -7.46%
Bionano Genomics
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.29
Upside: -
Sonoma Pharmaceuticals
Sep 5, 2023
Initiates: Buy
Price Target: $65
Current: $2.95
Upside: +2,103.39%
DraftKings
Jul 1, 2020
Initiates: Overweight
Price Target: $52
Current: $43.10
Upside: +20.65%
Sea Limited
Jul 1, 2020
Initiates: Overweight
Price Target: $130
Current: $175.05
Upside: -25.74%
Take-Two Interactive Software
May 21, 2020
Maintains: Equal-Weight
Price Target: $110 → $130
Current: $232.30
Upside: -44.04%